{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T06:57:24Z","timestamp":1722409044200},"reference-count":24,"publisher":"Wiley","issue":"s386","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":4527,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1995,4]]},"abstract":"<jats:p>Dysthymia is a relatively common disorder and is frequently associated with other mental conditions such as major depression and anxiety. A number of controlled and uncontrolled studies have indicated that conventional as well as more recent antidepressants such as moclobemide, a selective, reversible inhibitor of monoamine oxidase (MAOI), may be effective in dysthymia and dysthymia\u2010like disorders. However, assessment of the results of previous studies is confounded by the relative lack of standards in diagnostic criteria, outcome measures, dosage and duration of treatment. Applying DSM\u2010III\u2010R criteria, the efficacy of moclobemide in dysthymia has been confirmed in a significant study from South America, and other comparable studies are under way. The potential role of selective, reversible MAOIs such as moclobemide can be more firmly established when results of additional investigations have become available.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1995.tb05922.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T13:24:28Z","timestamp":1187875468000},"page":"36-39","source":"Crossref","is-referenced-by-count":8,"title":["Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia"],"prefix":"10.1111","volume":"91","author":[{"given":"H.","family":"P\u00e9tursson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Blakiston's new Gould medical dictionary","author":"Hoerr NL","year":"1956"},{"key":"e_1_2_1_3_2","first-page":"24","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1980"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770350030002"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790210031005"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(97)90002-X"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.6.689"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(80)90007-5"},{"key":"e_1_2_1_9_2","first-page":"49","article-title":"The effectiveness of tricyclic antidepressants in chronic depression","volume":"40","author":"Ward NG","year":"1979","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_10_2","first-page":"698","article-title":"Imipramine for treatment of chronic depression","volume":"21","author":"Kocsis JH","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800270071008"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014639"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.151.5.639"},{"issue":"7","key":"e_1_2_1_14_2","first-page":"346","article-title":"Phenelzine for chronic depression: a study of continuation treatment","volume":"47","author":"Harrison W","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92535-4"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb03196.x"},{"issue":"6","key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1192\/S0007125000297523","article-title":"A double\u2010blind comparative study of moclobemide versus imipramine and placebo in major depressive episodes","author":"Versiani M","year":"1989","journal-title":"Br J Psychiatry"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb10299.x"},{"issue":"6","key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1192\/S0007125000297535","article-title":"Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM\u2010III): an Austrian double\u2010blind multicentre study","author":"Baumhackl U","year":"1989","journal-title":"Br J Psychiatry"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1990.tb05319.x"},{"issue":"5","key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"185a","DOI":"10.1016\/0006-3223(92)90642-D","article-title":"Moclobemide in major depression and dysthymia","volume":"31","author":"Nazar J","year":"1992","journal-title":"Biol Psychiatry"},{"issue":"2","key":"e_1_2_1_22_2","first-page":"S55","article-title":"Efficacy of moclobemide in different patient groups","author":"Angst J","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"e_1_2_1_23_2","unstructured":"DuarteA CamozziCR.Moclobemide versus fluoxetine in the treatment of dysthymia. Abstracts of the 9th World Congress of Psychiatry Rio de Janeiro Brazil 6\u201312 June 1993."},{"key":"e_1_2_1_24_2","article-title":"Controlled comparison of Ro 11\u20131163 (moclobemide) and placebo in the treatment of depression","author":"Botte L","journal-title":"Acta Psychiatr Belg"},{"issue":"1","key":"e_1_2_1_25_2","first-page":"148b","article-title":"Moclobemide compared with imipramine in the treatment of chronic depression (dysthymia DSM\u2010III\u2010R): a double\u2010blind placebo\u2010controlled trial","volume":"15","author":"Versiani M","year":"1992","journal-title":"Clin Neuropharmacol"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1995.tb05922.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1995.tb05922.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T21:37:53Z","timestamp":1695764273000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1995.tb05922.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":24,"journal-issue":{"issue":"s386","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["10.1111\/j.1600-0447.1995.tb05922.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1995.tb05922.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}